Preventive Cardiovascular

LDL Levels Among Statin-Intolerant Adults

Primary and Secondary Prevention

Primary Cardiovascular Disease Prevention: Statin-Intolerant Adults

2023, N = 346

Patients referred to the Preventive Cardiology department for primary prevention who could not tolerate statins experienced reductions in low-density lipoprotein (LDL) levels. Patients were seen at baseline, defined as their first visit, and had at least 2 follow-up visits within the past 2 years. The time between visits varied from patient to patient.

LDL = low-density lipoprotein

Source: EPIC

Secondary Cardiovascular Disease Prevention: Statin-Intolerant Adults

2023, N = 492

Patients referred to the Preventive Cardiology department for secondary prevention who could not tolerate statins experienced reductions in low-density lipoprotein (LDL) levels. Patients were seen at baseline, defined as their first visit, and had at least 2 follow-up visits within the past 2 years. The time between visits varied from patient to patient.

LDL = low-density lipoprotein

Source: EPIC